Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shu L. Lu"'
Publikováno v:
Pharmacology & Toxicology. 86:228-233
Publikováno v:
Pharmacology and Toxicology. 86:228-233
1-(3'-Hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) has been extensively investigated as an orally effective iron chelator. In order to improve the pharmacokinetic and metabolic properties of CP41, eleven aromatic esters have been synthesised
Publikováno v:
Journal of Medicinal Chemistry. 42:4814-4823
The synthesis of a range of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described. The pK(a) values of the ligands and the stability constants of their iron(III) complexes hav
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 730:135-139
A gradient ion-pair HPLC separation of highly hydrophilic 3-hydroxypyridin-4-one (HPO) iron chelators is described. The ˚ separation of HPOs was performed using a reversed-phase polymer HPLC column (PLRP-S 100 A, 1530.46 cm ID, 5 mm). The ion-pair b
Publikováno v:
The Journal of pharmacy and pharmacology. 52(3)
To investigate the possibility of targeting chelators into the lysosomal iron pool, nine bidentate 3-hydroxypyridin-4-ones with basic chains have been synthesized. As the turnover of ferritin iron is centred in the lysosome, such strategy is predicte
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 21(4)
Hydrophilic 3-hydroxypyridin-4-ones (HPOs), such as 1-(2'-carboxyethyl)-2-methyl-3-hydroxypyridin-4-one (CP38), 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) and 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102), are orally act